NO892820D0 - Analogifremgangsmaate for fremstilling av terapeutisk aktive amidino-og guanidino-derivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive amidino-og guanidino-derivater.Info
- Publication number
- NO892820D0 NO892820D0 NO892820A NO892820A NO892820D0 NO 892820 D0 NO892820 D0 NO 892820D0 NO 892820 A NO892820 A NO 892820A NO 892820 A NO892820 A NO 892820A NO 892820 D0 NO892820 D0 NO 892820D0
- Authority
- NO
- Norway
- Prior art keywords
- amidino
- preparation
- therapeutically active
- analogy procedure
- guanidino derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/12—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C261/00—Derivatives of cyanic acid
- C07C261/04—Cyanamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/30—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
- C07C279/32—N-nitroguanidines
- C07C279/36—Substituted N-nitroguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8821330A IT1226389B (it) | 1988-07-12 | 1988-07-12 | Nuovi derivati ammidinici e guanidinici |
Publications (4)
Publication Number | Publication Date |
---|---|
NO892820D0 true NO892820D0 (no) | 1989-07-07 |
NO892820L NO892820L (no) | 1990-01-15 |
NO173093B NO173093B (no) | 1993-07-19 |
NO173093C NO173093C (no) | 1993-10-27 |
Family
ID=11180207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO892820A NO173093C (no) | 1988-07-12 | 1989-07-07 | Analogifremgangsmaate for fremstilling av terapeutisk aktive amidino-og guanidino-derivater |
Country Status (20)
Country | Link |
---|---|
US (1) | US5047410A (no) |
EP (1) | EP0351385A3 (no) |
JP (1) | JPH0285253A (no) |
KR (1) | KR900001678A (no) |
AU (1) | AU622918B2 (no) |
CZ (1) | CZ424289A3 (no) |
DD (1) | DD284013A5 (no) |
DK (1) | DK341589A (no) |
FI (1) | FI892993A (no) |
HU (1) | HUT52041A (no) |
IL (1) | IL90911A (no) |
IT (1) | IT1226389B (no) |
MX (1) | MX16754A (no) |
NO (1) | NO173093C (no) |
NZ (1) | NZ229889A (no) |
PL (2) | PL160812B1 (no) |
PT (1) | PT91122B (no) |
RU (1) | RU1776255C (no) |
YU (1) | YU138889A (no) |
ZA (1) | ZA895217B (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8928837D0 (en) * | 1989-12-21 | 1990-02-28 | Beecham Group Plc | Pharmaceuticals |
JPH06501002A (ja) * | 1990-08-30 | 1994-01-27 | オレゴン州 | シグマ受容体に対して高い結合性を有する置換アミジン類およびその使用 |
GB9214184D0 (en) * | 1992-07-03 | 1992-08-12 | Smithkline Beecham Plc | Pharmaceuticals |
TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
JP5086091B2 (ja) * | 2004-11-05 | 2012-11-28 | セラヴァンス, インコーポレーテッド | 5−ht4受容体アゴニスト化合物 |
ES2327142T3 (es) * | 2004-11-05 | 2009-10-26 | Theravance, Inc. | Compuestos de quinolinona-carboxamida. |
MX2007007818A (es) * | 2004-12-22 | 2007-09-11 | Theravance Inc | Compuestos de indazol-carboxamida. |
JP2008530225A (ja) * | 2005-02-17 | 2008-08-07 | セラヴァンス, インコーポレーテッド | インダゾール−カルボキサミド化合物の結晶型 |
BRPI0608392A2 (pt) * | 2005-03-02 | 2009-12-29 | Theravance Inc | compostos de quinolinona como agonistas do receptor 5-ht4 |
JOP20130213B1 (ar) | 2012-07-17 | 2021-08-17 | Takeda Pharmaceuticals Co | معارضات لمستقبلht3-5 |
WO2014049471A1 (en) * | 2012-09-29 | 2014-04-03 | Mahesh Kandula | Compositions and methods for the treatment of ventricular arrhythmias and cardiovascular diseases |
PL3201203T3 (pl) | 2014-09-29 | 2021-11-22 | Takeda Pharmaceutical Company Limited | Krystaliczna postać 1-(1-metylo-1h-pirazol-4-ilo)-n-((1r,5s,7s)-9-metylo-3-oksa-9-azabicyklo[3.3.1]nonan-7-ylo)-1h-indolo-3-karboksyamidu |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2531083B1 (fr) * | 1982-06-29 | 1986-11-28 | Sandoz Sa | Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments |
DE3304019A1 (de) * | 1983-02-07 | 1984-08-09 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 3-acyloxy-1-phenyl-2-aminocarbonylindol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
EP0191562B1 (en) * | 1985-01-23 | 1991-07-10 | Glaxo Group Limited | Tetrahydrocarbazolone derivatives |
EP0254584B1 (en) * | 1986-07-25 | 1992-10-07 | Beecham Group Plc | Azabicyclic compounds, process for their preparation, and their pharmaceutical use |
NL8701682A (nl) * | 1986-07-30 | 1988-02-16 | Sandoz Ag | Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten. |
IT1231238B (it) * | 1987-09-21 | 1991-11-26 | Angeli Inst Spa | Derivati ammidinici |
IT1228293B (it) * | 1989-02-06 | 1991-06-07 | Angeli Inst Spa | Benzoderivati di composti eterociclici contenenti azoto. |
-
1988
- 1988-07-12 IT IT8821330A patent/IT1226389B/it active
-
1989
- 1989-06-19 FI FI892993A patent/FI892993A/fi not_active Application Discontinuation
- 1989-07-07 NO NO892820A patent/NO173093C/no unknown
- 1989-07-10 NZ NZ229889A patent/NZ229889A/en unknown
- 1989-07-10 DD DD89330646A patent/DD284013A5/de not_active IP Right Cessation
- 1989-07-10 IL IL9091189A patent/IL90911A/en not_active IP Right Cessation
- 1989-07-10 PL PL1989280512A patent/PL160812B1/pl unknown
- 1989-07-10 ZA ZA895217A patent/ZA895217B/xx unknown
- 1989-07-10 PL PL1989295936A patent/PL161071B1/pl unknown
- 1989-07-11 PT PT91122A patent/PT91122B/pt not_active IP Right Cessation
- 1989-07-11 DK DK341589A patent/DK341589A/da not_active Application Discontinuation
- 1989-07-11 YU YU01388/89A patent/YU138889A/xx unknown
- 1989-07-11 RU SU894614427A patent/RU1776255C/ru active
- 1989-07-11 JP JP1178890A patent/JPH0285253A/ja active Pending
- 1989-07-11 MX MX1675489A patent/MX16754A/es unknown
- 1989-07-11 HU HU893490A patent/HUT52041A/hu unknown
- 1989-07-11 CZ CS894242A patent/CZ424289A3/cs unknown
- 1989-07-12 US US07/378,958 patent/US5047410A/en not_active Expired - Fee Related
- 1989-07-12 EP EP19890830325 patent/EP0351385A3/en not_active Ceased
- 1989-07-12 AU AU38038/89A patent/AU622918B2/en not_active Ceased
- 1989-07-12 KR KR1019890009896A patent/KR900001678A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO173093B (no) | 1993-07-19 |
PT91122B (pt) | 1995-01-31 |
YU138889A (en) | 1991-10-31 |
US5047410A (en) | 1991-09-10 |
CZ424289A3 (en) | 1994-12-15 |
PL160812B1 (pl) | 1993-04-30 |
AU622918B2 (en) | 1992-04-30 |
NO173093C (no) | 1993-10-27 |
FI892993A (fi) | 1990-01-13 |
DK341589A (da) | 1990-01-13 |
DK341589D0 (da) | 1989-07-11 |
ZA895217B (en) | 1991-03-27 |
DD284013A5 (de) | 1990-10-31 |
EP0351385A2 (en) | 1990-01-17 |
HUT52041A (en) | 1990-06-28 |
NZ229889A (en) | 1991-07-26 |
KR900001678A (ko) | 1990-02-27 |
RU1776255C (ru) | 1992-11-15 |
IT1226389B (it) | 1991-01-15 |
AU3803889A (en) | 1990-01-25 |
PT91122A (pt) | 1990-02-08 |
MX16754A (es) | 1993-10-01 |
IL90911A0 (en) | 1990-02-09 |
PL161071B1 (pl) | 1993-05-31 |
EP0351385A3 (en) | 1991-11-06 |
IL90911A (en) | 1994-05-30 |
JPH0285253A (ja) | 1990-03-26 |
NO892820L (no) | 1990-01-15 |
FI892993A0 (fi) | 1989-06-19 |
IT8821330A0 (it) | 1988-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO172801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater | |
NO164165C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater. | |
NO165023C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol- og furan derivater. | |
NO892820D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive amidino-og guanidino-derivater. | |
NO172240C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 2'-halometylidenderivater | |
NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
NO172849C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazol- og oksazol-derivater | |
NO891293D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol - og triazol-derivater. | |
NO890155L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
NO893909L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. | |
NO171857C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater | |
NO884176D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater. | |
NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO173061C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner | |
NO173185C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser | |
NO172802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner | |
NO891114L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
NO891009D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocyklokeptenderivater. | |
NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
NO892871D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
NO169589C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater | |
NO172538C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-fenoksymetyl-4-hydroksytetrahydropyran-2-oner og 6-tiofen-oksymetyl-4-hydroksytetrahydropyran-2-oner | |
NO892469L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-forbindelser. | |
NO890519D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater. | |
NO169486C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive allylaminoetylazoler |